Excessive islet NO generation in type 2 diabetic GK rats coincides with abnormal hormone secretion and is counteracted by GLP-1.
(2008) In PLoS ONE 3(5).- Abstract
- BACKGROUND: A distinctive feature of type 2 diabetes is inability of insulin-secreting beta-cells to properly respond to elevated glucose eventually leading to beta-cell failure. We have hypothesized that an abnormally increased NO production in the pancreatic islets might be an important factor in the pathogenesis of beta-cell dysfunction. PRINCIPAL FINDINGS: We show now that islets of type 2 spontaneous diabetes in GK rats display excessive NO generation associated with abnormal iNOS expression in insulin and glucagon cells, increased ncNOS activity, impaired glucose-stimulated insulin release, glucagon hypersecretion, and impaired glucose-induced glucagon suppression. Pharmacological blockade of islet NO production by the NOS inhibitor... (More)
- BACKGROUND: A distinctive feature of type 2 diabetes is inability of insulin-secreting beta-cells to properly respond to elevated glucose eventually leading to beta-cell failure. We have hypothesized that an abnormally increased NO production in the pancreatic islets might be an important factor in the pathogenesis of beta-cell dysfunction. PRINCIPAL FINDINGS: We show now that islets of type 2 spontaneous diabetes in GK rats display excessive NO generation associated with abnormal iNOS expression in insulin and glucagon cells, increased ncNOS activity, impaired glucose-stimulated insulin release, glucagon hypersecretion, and impaired glucose-induced glucagon suppression. Pharmacological blockade of islet NO production by the NOS inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME) greatly improved hormone secretion from GK islets suggesting islet NOS activity being an important target to inactivate for amelioration of islet cell function. The incretin hormone GLP-1, which is used in clinical practice suppressed iNOS and ncNOS expression and activity with almost full restoration of insulin release and partial restoration of glucagon release. GLP-1 suppression of iNOS expression was reversed by PKA inhibition but unaffected by the proteasome inhibitor MG132. Injection of glucose plus GLP-1 in the diabetic rats showed that GLP-1 amplified the insulin response but induced a transient increase and then a poor depression of glucagon. CONCLUSION: The results suggest that abnormally increased NO production within islet cells is a significant player in the pathogenesis of type 2 diabetes being counteracted by GLP-1 through PKA-dependent, nonproteasomal mechanisms. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1154188
- author
- Salehi, S Albert LU ; Meidute Abaraviciene, Sandra ; Jimenez, Javier LU ; Ostenson, Claes-Göran ; Efendic, Suad and Lundquist, Ingmar LU
- organization
- publishing date
- 2008
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- islet hormone secretion, ncNOS, Diabetic GK rat, iNOS, NOS inhibition, GLP-1
- in
- PLoS ONE
- volume
- 3
- issue
- 5
- article number
- e2165
- publisher
- Public Library of Science (PLoS)
- external identifiers
-
- wos:000262172800030
- pmid:18478125
- scopus:47749085111
- ISSN
- 1932-6203
- DOI
- 10.1371/journal.pone.0002165
- language
- English
- LU publication?
- yes
- id
- 002813cf-bc1f-49b1-9201-02e9fbebc4b2 (old id 1154188)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/18478125?dopt=Abstract
- http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0002165
- date added to LUP
- 2016-04-04 09:08:38
- date last changed
- 2022-02-13 07:57:24
@article{002813cf-bc1f-49b1-9201-02e9fbebc4b2, abstract = {{BACKGROUND: A distinctive feature of type 2 diabetes is inability of insulin-secreting beta-cells to properly respond to elevated glucose eventually leading to beta-cell failure. We have hypothesized that an abnormally increased NO production in the pancreatic islets might be an important factor in the pathogenesis of beta-cell dysfunction. PRINCIPAL FINDINGS: We show now that islets of type 2 spontaneous diabetes in GK rats display excessive NO generation associated with abnormal iNOS expression in insulin and glucagon cells, increased ncNOS activity, impaired glucose-stimulated insulin release, glucagon hypersecretion, and impaired glucose-induced glucagon suppression. Pharmacological blockade of islet NO production by the NOS inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME) greatly improved hormone secretion from GK islets suggesting islet NOS activity being an important target to inactivate for amelioration of islet cell function. The incretin hormone GLP-1, which is used in clinical practice suppressed iNOS and ncNOS expression and activity with almost full restoration of insulin release and partial restoration of glucagon release. GLP-1 suppression of iNOS expression was reversed by PKA inhibition but unaffected by the proteasome inhibitor MG132. Injection of glucose plus GLP-1 in the diabetic rats showed that GLP-1 amplified the insulin response but induced a transient increase and then a poor depression of glucagon. CONCLUSION: The results suggest that abnormally increased NO production within islet cells is a significant player in the pathogenesis of type 2 diabetes being counteracted by GLP-1 through PKA-dependent, nonproteasomal mechanisms.}}, author = {{Salehi, S Albert and Meidute Abaraviciene, Sandra and Jimenez, Javier and Ostenson, Claes-Göran and Efendic, Suad and Lundquist, Ingmar}}, issn = {{1932-6203}}, keywords = {{islet hormone secretion; ncNOS; Diabetic GK rat; iNOS; NOS inhibition; GLP-1}}, language = {{eng}}, number = {{5}}, publisher = {{Public Library of Science (PLoS)}}, series = {{PLoS ONE}}, title = {{Excessive islet NO generation in type 2 diabetic GK rats coincides with abnormal hormone secretion and is counteracted by GLP-1.}}, url = {{http://dx.doi.org/10.1371/journal.pone.0002165}}, doi = {{10.1371/journal.pone.0002165}}, volume = {{3}}, year = {{2008}}, }